Product Portfolio
Product Portfolio
- Whole Genome
- Whole Exome
- Cardiovascular
- Oncology
- Pharmacogenomic – Core
- Neurological
- Carrier
- Pharmacogenomic – Advanced
- Nutritional
Whole Genome Screening
Comprehensive genomic risk screening for generally healthy adults across cancer, cardiovascular, and immune-related conditions.
Whole Exome Sequencing
Broad genetic analysis for individuals with a family history or suspected hereditary condition.
Cardiovascular Genetic Panel
Hereditary heart disease risk screening across arrhythmias, cardiomyopathies, and related conditions.
Hereditary Cancer Risk Panel
Comprehensive multi-gene panel screening for hereditary cancer risk across proto-oncogenes, kinases, transcription factors, and tumor suppressors.
Pharmacogenomic Panel
Core genetic factors influencing drug metabolism and medication response.
Neurological Genetic Panel
Hereditary neurological condition screening.
Carrier Screening Panel
Genetic screening for couples family planning.
Advanced Pharmacogenomic Panel
Expanded medication-management panel across multiple specialties.
Nutritional Genetics Panel
Genetic markers for personalized dietary and nutrition planning.
All panels performed through CLIA/CAP-certified reference laboratory partners.
Understanding Genomic Testing Options
What is whole genome sequencing?
Whole genome sequencing examines a broad range of DNA across the genome.
It can provide information about many different types of genetic variation and may be considered when a physician is looking for a broad view of an individual’s genomic information.
What is whole exome sequencing?
Whole exome sequencing focuses mainly on the portions of genes that contain instructions for making proteins.
It may be considered when a physician is evaluating a suspected inherited condition or when family and medical history suggest that broader genetic evaluation could be useful.
What is hereditary cancer genetic testing?
Hereditary cancer testing looks for genetic variations associated with an inherited predisposition to certain cancers.
The information may help physicians assess inherited risk together with the patient’s personal and family cancer history.
What is cardiovascular genetic testing?
Cardiovascular genetic testing looks for genetic variations associated with certain inherited heart and cardiovascular conditions.
It may be considered when a patient’s history or family history suggests a possible inherited cardiovascular risk.
What is pharmacogenomic testing?
Pharmacogenomic testing looks at genetic factors that may influence how a person responds to certain medications.
Physicians may use this information together with other clinical factors when considering medication management.
What is carrier screening?
Carrier screening looks for genetic variations that a person may carry for certain inherited conditions.
It can be relevant to individuals or couples who are planning a family and want additional information about potential inherited risks.